Interviews from Asembia's AXS24 Summit, Part 1 of 2

Asembia’s AXS24 Summit, a pinnacle of specialty drug and healthcare discussions, concluded earlier this month. We are thrilled to share that our podcast was selected as a media partner for this esteemed event. This is the first of two episodes dedicated to AXS24, where Scott and Mark had the opportunity to interview several key speakers and attendees. In this episode, we bring you the insights of Melissa Paige, a seasoned healthcare professional and President of the National Association of Medication Access & Patient Advocacy, who led a session on the Patient Financial Impact of IRA. We also present the perspectives of Renee Rayburg, RPh., VP, Clinical Strategy, Pharmaceutical Strategy Group and Morgan Lee, PhD, MPH, CPH, Senior Director, Research & Strategy, PSG, who are renowned for their study and session on Viewpoints in Specialty Drug Benefit Design. Melissa Paige, President, (NAMAPA)University of Virginia Health SystemAsembiaInflation Reduction ActDr. Madelaine FeldmanRenee Rayburg, Vice President Specialty Clinical Consulting, Artemetrx, Morgan Lee, PhD, Senior Director, PSGPharmacy Benefit Managers (PBMs)GoodRx2024 Trends in Specialty Drug Benefits ReportMedical terminology referenced in this episode:Generic ARBs Multiple SclerosisHumira biosimilarsAlbuterol inhalerEmail us:[email protected] us on X, LinkedIn, YouTube and Threads.